News 2017-02-17
Porton’s Annual Senior Management Working Conference.
Chongqing,China,February 17,2017: Porton Fine Chemicals, Ltd. held its annual senior management working conference on February 17, 2017. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed the Company’s progress made during 2016 and forward plans for 2017. Oliver Ju and Andrew Xu lauded the efforts of Porton’s employees towards achievement of FY 2016 revenue targets, and summarized the Company’s strategic initiatives for continued growth in FY 2017 and beyond.
Others
More
News 2025-04-16
Porton Advanced's End-to-End CDMO Solutions Accelerates IND Approval of Tasly's Innovative Dual-Targeting CAR-T Therapy
April 12, 2025 - Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD’s Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) approval from China's National Medical Products Administration (NMPA) (Approval No.: 2025LP01030). This breakthrough CAR-T therapy is indicated for recurrent glioblastoma (GBM).

News 2025-04-11
Porton Newsletter - March 2025 Recap
Technical Enabling Services & Solutions Company Events ESG Marketing Activities